Wheat bran, while a nutritious and economic feed ingredient, contents high levels of non-starch polysaccharides which entraps nutrients and interferes digestion and absorption. To study the influence of fermented wheat bran by xylanase-producing Bacillus cereus on growth performance and intestinal microflora of broiler chickens, a total of 180 broilers (21-day-old, mixed of male and female) were randomly divided into 3 treatments, with 6 replicates in each treatment and 10 broilers in each replicate: 1) control check ( CK ), corn-soybean meal-based diet; 2) wheat bran group ( WB ), 5% of the corn were replaced with wheat bran; and 3) fermented wheat bran group ( FWB ), 5% of the corn were replaced with fermented wheat bran. Growth performance was determined in the period of 21- to 42-day-old. Intestinal digestive enzyme activities and microbiota diversity were analyzed on day 42. No differences were observed on growth performance among treatments ( P > 0.05). The activity of amylase in the duodenum of FWB was 1.56 times higher than CK ( P < 0.05). The Chao1 index of microbiota in cecum of FWB increased 24.26% compared with CK ( P < 0.01). The amount of Bifidobacteriaceae in cecum of WB was 29.1 times and 15.8 times higher than CK and FWB ( P < 0.05) respectively. Principal co-ordinates analysis in cecum revealed the dissimilarity microbiota among treatments. In summary, the use of fermented wheat bran to partially replace corn (5%) in diets had no adverse effect on growth performance and triggered beneficial effects such as increasing duodenal amylase activity and intestinal microflora abundance in broiler chickens. These observations support that solid-state fermentation by xylanase-producing Bacillus cereus is feasible approach to pre-treat wheat bran for feedstuff industry.
The aim of this study was to explore the effect of short-chain inulin on cecal microbiota of high-fat diet-fed leptin knockout mice and the different influences of cecal microbiota on wild-type and leptin knockout mice. A total of 18 specific pathogen-free male C57BL/6J wild-type mice and 18 C57BL/6J leptin knockout mice (OB/OB mice) were selected. Mice were divided into six groups according to their genotype: wild-type mice have three groups, including the normal diet group (CT), 60% high-fat diet group (CH), and 60% high fat with 10% short-chain inulin group (CHI); OB/OB mice were also divided into three groups, including the normal diet group (OT), 60% high-fat diet group (OH), and 60% high fat with 10% short-inulin group (OHI). The mice were fed for 8 weeks to analyze the diversity of cecal microbiota. The results show that compared with CH and OH, the variety of cecal microbiota was significantly reduced in CH and OH and further reduced in CHI and OHI. Bifidobacterium and Lactobacillus are the biomarkers in genus level. Dietary short-chain inulin significantly enhanced Bifidobacterium in OHI compared with OH (p < 0.01) and significantly reduced in CHI and compared with CH (p < 0.01). Lactobacillus was significantly enhanced in CHI and OHI compared with CH and OH, respectively (p < 0.01). Blautia was significantly enhanced in CH and OH compared with other groups (p < 0.01). Both Escherichia-Shigella and Enterococcus were significantly reduced in CHI and OHI, compared with CH and OH, respectively (p < 0.05). Escherichia-Shigella was even lower than CT and OT in CHI and OHI. Functional prediction of microbial communities showed that the abundance of amino acid sugar and nucleotide sugar metabolism pathways were significantly enhanced (p < 0.05) in CH and OH, and OH was significantly higher than CH (p < 0.05). Among the leptin knockout groups, PICRUSt2 function prediction showed that the fatty acid metabolism pathway significantly reduced (p < 0.05) in OHI and OT compared with OH. In conclusion, short-chain inulin modulated the dysbiosis induced by high-fat diet, improved probiotics growth and inhibited conditioned pathogenic bacteria, and the influences were significantly different in wild-type and leptin knockout mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.